| Document And Entity Information | Mar. 03, 2025 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Mar. 03, 2025 |
| Entity Registrant Name | SYNDAX PHARMACEUTICALS, INC. |
| Entity Central Index Key | 0001395937 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-37708 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 32-0162505 |
| Entity Address, Address Line One | 730 Third Avenue |
| Entity Address, Address Line Two | Floor 9 |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10017 |
| City Area Code | (781) |
| Local Phone Number | 419-1400 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock |
| Trading Symbol | SNDX |
| Security Exchange Name | NASDAQ |
